Page last updated: 2024-09-03

ym 529 and tetradecanoylphorbol acetate

ym 529 has been researched along with tetradecanoylphorbol acetate in 1 studies

Compound Research Comparison

Studies
(ym 529)
Trials
(ym 529)
Recent Studies (post-2010)
(ym 529)
Studies
(tetradecanoylphorbol acetate)
Trials
(tetradecanoylphorbol acetate)
Recent Studies (post-2010) (tetradecanoylphorbol acetate)
140237131,050612,217

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hanai, Y; Harada, A; Kozawa, O; Ohta, T; Takai, S; Tokuda, H1

Other Studies

1 other study(ies) available for ym 529 and tetradecanoylphorbol acetate

ArticleYear
Minodronate suppresses prostaglandin F2alpha-induced vascular endothelial growth factor synthesis in osteoblasts.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2006, Volume: 38, Issue:3

    Topics: Animals; Cell Line; Dinoprost; Diphosphonates; Imidazoles; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Osteoblasts; Phosphorylation; Protein Kinase C; Proto-Oncogene Proteins c-raf; Tetradecanoylphorbol Acetate; Vascular Endothelial Growth Factor A

2006
chemdatabank.com